These sweeteners may come from plant sources, undergo less processing, or have a lower glycemic index (GI), making them more suitable for people with dietary restrictions, including diabetics, GLP-1 users, and those following ketogenic or paleo diets
Morgan Stanley estimated that 7% of the US population, or 24 million people, will be taking hunger-suppressing weight-loss drugs by 2035 cutting their daily calorie consumption by as much as 30%, according to the firm, which surveyed over 300 patients
One GLP-1RA, liraglutide, has been approved to treat obesity, and another, semaglutide, is in clinical trials
So far, Eli Lilly's tirzepatide Mounjaro has been approved for diabetes and weight loss indications in China
Always follow the patient information leaflet supplied with your medication and seek guidance from your pharmacist if you are unsure of any step
Customer Support & Reviews Reviews on Reddit and Trustpilot are mixed, yet many patients consistently mention fast delivery and promising initial outcomes
